KCA’s Research Intern Outlines Grant Impact
This is a guest post by Liam Piscetelli, the KCA’s 2024 Research Intern. For the past 8 months, I have interned with the KCA as a research intern. As a student working towards their Masters…
This is a guest post by Liam Piscetelli, the KCA’s 2024 Research Intern. For the past 8 months, I have interned with the KCA as a research intern. As a student working towards their Masters…
A retrospective analysis of just over 100 people with metastatic chromophobe renal cell carcinoma (RCC) showed that patients given first-line doublet therapy – two drugs simultaneously – had superior outcomes compared to patients given a…
Among a trio of biomarker studies presented at the 2024 meeting of the American Society of Clinical Oncology, one stood out as having potential predictive and prognostic value for some kidney cancer patients. Presented by…
Welcome to our new blog series where we distill the latest in kidney cancer clinical trials into essential updates for patients, caregivers, and those tracking advancements in this field. With 87 new interventional studies since…
The Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts recently recognized the Kidney Cancer Association (KCA) for supporting researchers at the institution with over $1 million in funding. KCA’s name was placed on the DFCI’s Benefactors…
This is a guest post by D’Ann George, PhD, Medical Writer. Some kidney cancers are so rare that clinicians don’t know enough about them to determine what treatments should be standard, or even to predict…
We rounded up a few research highlights from the 2024 ASCO Genitourinary Cancers Symposium (ASCO GU), held recently in San Francisco, California. Adjuvant immunotherapy improved survival after nephrectomy and could be new standard of care Researchers are…
This is a guest post by Dr. Arpita Desai, an oncologist at the University of California San Francisco specializing in genitourinary cancers. She summarized the results and takeaways for patients from key trials presented at…
This is a guest post by D’Ann George, PhD, Medical Writer. Joel Stern vividly remembers the first time he saw the phrase palliative care in his medical file. At the time, in 2020, Stern had…
This is a guest post by Dr. Pavlos Msaouel, a medical oncologist and researcher at MD Anderson Cancer Center, renal medullary carcinoma expert, and member of the KCA’s Medical Steering Committee. Dr. Msaouel has also…